title: Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.
abstract: Obsessive-compulsive disorder (OCD) is a debilitating condition that afflicts approximately 1% to 3% of the world population. The primary treatments are selective serotonin reuptake inhibitors and behavioral therapy. Despite therapy, approximately 30% to 40% of patients continue to suffer from disabling OCD symptoms. This article addresses the range of treatment options for patients with refractory OCD, focusing upon novel strategies and the most recent research.
authors: Anxiety Disorders Clinic, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.
authors: L D
authors: LD
authors: Kochan
authors: A I
authors: AI
authors: Qureshi
authors: B A
authors: BA
authors: Fallon
mesh_terms: D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003376:Counseling; D004351:Drug Resistance; D004565:Electroconvulsive Therapy; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D015013:Yoga
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors